Program snapshot
- 21 Australian pathology markers extracted for this 61-year-old male; 16 within optimal range, 3 above range, 0 below range.
- Cardiovascular and metabolic domains carry the priority watch items this cycle.
Example preview — not real patient data
Biological Age Tracker — your Patient Portal (example)
“J Smith” is a demo patient used to show a fully completed example of your own Patient Portal. This page is static — it does not submit, store or send any data.
Patient portal
Biological Age Tracker
Your doctor-approved Biological Age report is shown here after your doctor publishes it to your portal. Doctor workflow cards are not shown in the patient portal.
Published patient report
J Smith
61 · Male · Latest collection 4 Jul 2026
Markers: 21 · Review: 3 · Missing: 0 · Status: Published
Published Biological Age Tracker
| Biomarker / Category | Age Trend | Australian Reference Range | Date / latest value | Unit | Status | Doctor note |
|---|---|---|---|---|---|---|
| Renal (Kidney) & Metabolic Function | ||||||
| 🩸 Cystatin C | ▲ | 0.60 - 1.10 mg/L | 1.154 Jul 2026 | mg/L | Review | Mild elevation, recheck with fasting glucose. |
| 🩸 HbA1c | ▲ | < 5.7 % | 5.54 Jul 2026 | % | In range | — |
| 🩸 Fasting Glucose | ▲ | 3.0 - 5.4 mmol/L | 5.64 Jul 2026 | mmol/L | Review | Early metabolic trend, watch-list. |
| 🩸 Urea | ▲ | 2.5 - 8.0 mmol/L | 5.84 Jul 2026 | mmol/L | In range | — |
| 🩸 Creatinine | ▲ | 60 - 110 µmol/L (Male) | 984 Jul 2026 | µmol/L | In range | — |
| Liver & Gallbladder Function | ||||||
| 🫀 Gamma-Glutamyl Transferase (GGT) | ▲ | < 60 U/L (Male) | 384 Jul 2026 | U/L | In range | — |
| 🫀 Alkaline Phosphatase (ALP) | ▲ | 30 - 110 U/L | 724 Jul 2026 | U/L | In range | — |
| 🫀 Alanine Aminotransferase (ALT) | ▼ | < 45 U/L (Male) | 324 Jul 2026 | U/L | In range | — |
| 🫀 Albumin | ▼ | 35 - 50 g/L | 434 Jul 2026 | g/L | In range | — |
| Immune System & Inflammation | ||||||
| 🛡️ High-Sensitivity CRP (hsCRP) | ▲ | < 5.0 mg/L (optimal < 1.0) | 1.84 Jul 2026 | mg/L | In range | Above the optimal target — watch-list. |
| 🛡️ Neutrophils (Absolute) | ▲ | 2.0 - 7.5 x10^9/L | 4.24 Jul 2026 | x10^9/L | In range | — |
| 🛡️ Lymphocyte Percentage | ▼ | 20.0 - 40.0 % | 324 Jul 2026 | % | In range | — |
| 🛡️ Monocytes (Absolute) | ▲/▼ | 0.2 - 0.8 x10^9/L | 0.54 Jul 2026 | x10^9/L | In range | — |
| Blood Health & Hematology (RBCs) | ||||||
| 🔬 Red Cell Distribution Width (RDW) | ▲ | 11.5 - 14.5 % | 13.14 Jul 2026 | % | In range | — |
| 🔬 Mean Corpuscular Volume (MCV) | ▲ | 80 - 100 fL | 914 Jul 2026 | fL | In range | — |
| 🔬 Mean Corpuscular Hemoglobin (MCH) | ▲/▼ | 27 - 32 pg | 304 Jul 2026 | pg | In range | — |
| 🔬 Red Blood Cell Count (RBC) | ▼ | 4.5 - 5.9 x10^12/L (Male) | 4.94 Jul 2026 | x10^12/L | In range | — |
| Cardiovascular, Lipid & Hormonal | ||||||
| ❤️ Total Cholesterol | ▲ | < 5.5 mmol/L | 5.84 Jul 2026 | mmol/L | Review | Diet and lipid recheck in 3-4 months. |
| ❤️ Apolipoprotein A1 (ApoA1) | ▲/▼ | 1.10 - 2.05 g/L | 1.454 Jul 2026 | g/L | In range | — |
| ❤️ Sex Hormone-Binding Globulin (SHBG) | ▲ | 15 - 70 nmol/L (Male) | 424 Jul 2026 | nmol/L | In range | — |
| ❤️ Vitamin D - 25(OH)D | ▼ | > 50 nmol/L (optimal 75-150) | 584 Jul 2026 | nmol/L | In range | Below optimal target — watch-list. |
Doctor-approved program and health stack
Nutrition
- Reduce refined carbohydrate load given the fasting-glucose trend; prioritise fibre and protein at breakfast.
- Shift toward a Mediterranean-pattern diet to support the elevated cholesterol finding.
Vitamins & minerals
- Vitamin D3 2000 IU/day toward the optimal 75–150 nmol/L target.
Exercise
- 150 min/week zone-2 aerobic work plus 2× resistance sessions for metabolic and renal support.
Lifestyle
- Sleep and alcohol review given the mild inflammatory and metabolic markers.
Follow-up testing
- Repeat Cystatin C, fasting glucose, hsCRP and lipid panel in 3–4 months.
Nutritional support
- Food-first foundation matched to a 61-year-old male: adequate protein, fibre and whole-food density as described in the nutrition plan.
Evidence-informed supplements
- Omega-3 (EPA/DHA) 1–2 g/day — cardiovascular and anti-inflammatory support, pending anticoagulant check.
Doctor-only peptide review
- No peptide is released automatically to the patient.
- Doctor may add, edit or remove peptide options only after consultation, consent and clinical justification against these results.
Doctor notes: Agree with the draft. Added a note on alcohol intake and confirmed no medication interactions with the supplement stack. Maintain current lifestyle protocol, recheck the flagged markers in 3-4 months.
This Biological Age Tracker is provided for educational and wellness-support purposes only. It does not provide medical diagnosis, treatment, or personalised medical advice. Laboratory results and recommendations must be reviewed by a qualified medical practitioner before any action is taken. Product, nutrition, exercise, supplement, or peptide-related suggestions must only be followed after approval by the treating doctor.